The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of S-1 and cisplatin combination versus S-1 adjuvant chemotherapy for advanced gastric cancer.
Hyo Song Kim
No relevant relationships to disclose
Hei-Cheul Jeung
No relevant relationships to disclose
Minkyu Jung
No relevant relationships to disclose
Hye Ryun Kim
No relevant relationships to disclose
Ji Yeong Ahn
No relevant relationships to disclose
Hyoung-Il Kim
No relevant relationships to disclose
Jae-Ho Cheong
No relevant relationships to disclose
Woo Jin Hyung
No relevant relationships to disclose
Sung Hoon Noh
No relevant relationships to disclose
Hyun Cheol Chung
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose